Results
|
2781.
|
The same site on the integrase-binding domain of lens epithelium-derived growth factor is a therapeutic target for MLL leukemia and HIV. [electronic resource] by
- Murai, Marcelo J
- Pollock, Jonathan
- He, Shihan
- Miao, Hongzhi
- Purohit, Trupta
- Yokom, Adam
- Hess, Jay L
- Muntean, Andrew G
- Grembecka, Jolanta
- Cierpicki, Tomasz
Producer: 20150220
In:
Blood vol. 124
Availability: No items available.
|
|
2782.
|
|
|
2783.
|
Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults. [electronic resource] by
- Gallant, Joel E
- Thompson, Melanie
- DeJesus, Edwin
- Voskuhl, Gene W
- Wei, Xuelian
- Zhang, Heather
- White, Kirsten
- Cheng, Andrew
- Quirk, Erin
- Martin, Hal
Producer: 20170616
In:
Journal of acquired immune deficiency syndromes (1999) vol. 75
Availability: No items available.
|
|
2784.
|
|
|
2785.
|
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study. [electronic resource] by
- Molina, Jean-Michel
- Lamarca, Anthony
- Andrade-Villanueva, Jaime
- Clotet, Bonaventura
- Clumeck, Nathan
- Liu, Ya-Pei
- Zhong, Lijie
- Margot, Nicolas
- Cheng, Andrew K
- Chuck, Steven L
Producer: 20120217
In:
The Lancet. Infectious diseases vol. 12
Availability: No items available.
|
|
2786.
|
|
|
2787.
|
|
|
2788.
|
|
|
2789.
|
|
|
2790.
|
|
|
2791.
|
|
|
2792.
|
|
|
2793.
|
|
|
2794.
|
Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort. [electronic resource] by
- Capetti, Amedeo F
- Sterrantino, Gaetana
- Cossu, Maria Vittoria
- Orofino, GianCarlo
- Barbarini, Giorgio
- De Socio, Giuseppe V
- Di Giambenedetto, Simona
- Di Biagio, Antonio
- Celesia, Benedetto M
- Argenteri, Barbara
- Rizzardini, Giuliano
Producer: 20170522
In:
PloS one vol. 11
Availability: No items available.
|
|
2795.
|
|
|
2796.
|
|
|
2797.
|
|
|
2798.
|
|
|
2799.
|
|
|
2800.
|
|